Tandem Diabetes Care, Inc.Tandem Diabetes Care, Inc.Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc.

No trades
See on Supercharts

Price target

53.350.000.00%
The 20 analysts offering 1 year price forecasts for TNDM have a max estimate of — and a min estimate of —.

Analyst rating

Based on 23 analysts giving stock ratings to TNDM in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


TNDM EPS for the last quarter is −0.35 USD despite the estimation of −0.41 USD. In the next quarter EPS is expected to reach −0.21 USD. Track more of Tandem Diabetes Care, Inc. financials and stay on top of what is up with the company.
In the next quarter Tandem Diabetes Care, Inc. revenue is expected to reach ‪249.81 M‬ USD. Check out Tandem Diabetes Care, Inc. revenue and earnings and make informed decisions.
According to analysts, TNDM price target is 53.35 USD with a max estimate of 75.00 USD and a min estimate of 18.00 USD. Check if this forecast comes true in a year, meanwhile watch Tandem Diabetes Care, Inc. stock price chart and keep track of the current situation with TNDM news and stock market news.
We've gathered opinions of 23 analysts rating TNDM stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.